NCT03478904 2021-05-10Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate CancerNational Institutes of Health Clinical Center (CC)Phase 1 Terminated1 enrolled 8 charts